Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$75,986,174
-$1,934,174 QoQ
Shares Held
209,837
-5.2% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#174
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. AMGN ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
357,284 | $428,537,182 | |
| 2 | JNJ |
Johnson & Johnson
|
1,192,228 | $302,790,144 | |
| 3 | ABBV |
AbbVie Inc.
|
680,811 | $171,319,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,305,364 | $167,739,274 | |
| 5 | PFE |
Pfizer Inc
|
6,943,719 | $167,204,752 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,414,008 | $81,475,140 | |
| 7 | AMGN |
Amgen Inc
This page
|
209,837 | $75,986,174 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525,655 | $66,411,252 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,986,174 | 209,837 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $77,920,348 | 221,459 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $64,848,620 | 198,126 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $76,572,147 | 271,340 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $74,062,685 | 265,258 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $86,953,293 | 279,099 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $67,955,103 | 260,724 | Shares | Defined | 2025-12-09 | |
| 2024-09-30 | $49,267,841 | 152,906 | Shares | Defined | 2025-12-09 | |
| 2024-06-30 | $54,951,518 | 175,873 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $32,193,837 | 113,231 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $37,469,961 | 130,095 | Shares | Defined | 2025-12-09 | |
| 2023-09-30 | $39,606,891 | 147,369 | Shares | Defined | 2025-12-09 | |
| 2023-06-30 | $26,313,810 | 118,520 | Shares | Defined | 2025-12-09 | |
| 2023-03-31 | $29,013,384 | 120,014 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $36,980,499 | 140,803 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $33,507,963 | 148,660 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $31,025,615 | 127,520 | Shares | Defined | 2025-12-09 | |
| 2022-03-31 | $30,518,167 | 126,202 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $29,555,432 | 131,375 | Shares | Defined | 2025-12-29 | |
| 2021-09-30 | $26,818,567 | 126,116 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $25,528,451 | 123,965 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $30,043,558 | 120,749 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $29,998,121 | 130,472 | Shares | Defined | 2025-12-29 | |
| 2020-09-30 | $58,347,511 | 229,570 | Shares | Defined | 2025-12-29 | |
| 2020-06-30 | $49,554,421 | 210,101 | Shares | Defined | 2025-12-29 | |
| 2020-03-31 | $42,313,399 | 208,718 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||